Bleomycin for Percutaneous Sclerotherapy of Venous and Lymphatic Malformations: A Retrospective Study of Safety, Efficacy and Mid-Term Outcomes in 26 Patients

Bleomycin for Percutaneous Sclerotherapy of Venous and Lymphatic Malformations: A Retrospective Study of Safety, Efficacy and Mid-Term Outcomes in 26 Patients

Percutaneous sclerotherapy is used to treat venous and lymphatic vascular malformations, which can cause significant discomfort and/or disfigurement. The purpose of this study is to describe the bleomycin sclerotherapy technique and to evaluate its clinical and radiological efficacy and safety. We r...

Full description

Bibliographic Details
Main Authors: Franck Nevesny, Olivier Chevallier, Nicolas Falvo, Kévin Guillen, Alexandre Malakhia, Julie Pellegrinelli, Pierre-Olivier Comby, Bertille Bonniaud, Marco Midulla, Romaric Loffroy
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Clinical Medicine
Subjects:
venous malformations
lymphatic malformations
percutaneous sclerotherapy
bleomycin
patient-reported outcomes
Online Access:https://www.mdpi.com/2077-0383/10/6/1302

Internet

https://www.mdpi.com/2077-0383/10/6/1302

Similar Items